Lipocine Inc.
LPCNNASDAQHealthcare● Active
$2.11
+$0.07(+3.19%)
Market Cap$12216382
P/E Ratio—
52W High$12.37
52W Low$1.81
Lipocine Inc.（LPCN）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LPCN · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.98M | $11.20M | ($2.85M) | $0.50M | $16.14M |
| Cost of Revenue | $8.58M | $0.00M | $10.18M | $8.56M | $7.67M |
| Gross Profit | ($6.61M) | $11.20M | ($13.03M) | ($8.06M) | $8.48M |
| Gross Margin %(computed) | -334.26% | 100.00% | 456.92% | — | 52.51% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $7.35M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $3.76M | $5.00M | $4.90M | $4.06M | $5.33M |
| Total Operating Expenses | $3.76M | $12.35M | $4.90M | $4.06M | $5.33M |
| Operating Income | ($10.37M) | ($1.16M) | ($17.93M) | ($12.12M) | $3.15M |
| Operating Margin %(computed) | -524.69% | -10.31% | 628.98% | — | 19.49% |
| Interest Income | $0.74M | $1.15M | $1.37M | $0.57M | $0.07M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.03M | $0.20M |
| Income Before Tax | ($9.63M) | $0.01M | ($16.35M) | ($10.76M) | ($0.63M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($9.63M) | $0.01M | ($16.35M) | ($10.76M) | ($0.63M) |
| Net Margin %(computed) | -487.06% | 0.07% | 573.59% | — | -3.93% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.77 | $0.00 | $-3.14 | $-2.15 | $-0.19 |
| Wtd Avg Shares | 5.45M | 5.34M | 5.27M | 4.99M | 3.30M |
| EBITDA | ($10.31M) | ($1.11M) | ($17.90M) | ($10.72M) | ($0.43M) |
| EBITDA Margin %(computed) | -521.61% | -9.95% | 627.97% | — | -2.67% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Lipocine Inc.
关于Lipocine Inc.（LPCN）损益表
Lipocine Inc.（LPCN）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LPCN实现营收$0.00B，毛利润($0.01B)（毛利率-334.26%），净利润($0.01B)（净利率-487.06%）。
常见问题
LPCN · 4 问Lipocine Inc.（LPCN）2025财年营收为$0.00B，同比down82.3%。
LPCN revenueLPCN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09